1. Bigwarfe, T., Abbott, M., DeVona, D., Gonchoroff, D., Haggerty, H.G., McAvoy, E., Phelps, L., Price, K. and Reilly, T. (2004): T-cell-dependent antibody responses to keyhole limpet hemocyanin (KLH) in pre-clinical immunotoxicity testing. The Toxicologist/Toxicol. Sci., 78, 429.
2. Finco-Kent, D. and Kawabata, T.T. (2005): Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation. J. Immunotoxicol., 2, 197-201.
3. Gore, E.R. (2006): Immune function tests for hazard identification: a paradigm shift in drug development. Basic Clin. Pharmacol. Toxicol., 98, 331-335.
4. Gore, E.R., Gower, J., Kurali, E., Sui, J.L., Bynum, J., Ennulat, D. and Herzyk, D.J. (2004): Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology, 197, 23-35.
5. ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use) M3(R2) Guideline (2009): Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals M3(R2). ICH.